Prevalence of beta-lactamase production in H. influenzae isolated in Latin America in 1998-1999: results of the LASER study

Int J Antimicrob Agents. 2002 Mar;19(3):201-5. doi: 10.1016/s0924-8579(02)00004-3.

Abstract

The objective of this study was to assess the prevalence of beta-lactamase production in Haemophilus influenzae clinical isolates obtained throughout Latin America and the West Indies in 1998-1999. Isolates were collected from 15 centres (seven countries), identified by standard methods and grouped by patient age. The overall prevalence of beta-lactamase production was 17.8% (270/1513 isolates). The prevalence of beta-lactamase positive strains varied between countries, with the highest prevalence detected in Panama (23.4%, 29/124) and the lowest in the West Indies (10.5%, 4/38). beta-Lactamase-positive strains were more frequently isolated from children aged < or =3 years (22.0%) and from adults aged > or =65 years (26.5%). The high prevalence of beta-lactamase production found should be considered when choosing empirical antibiotic therapy where H. influenzae is suspected.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / pharmacology
  • Child, Preschool
  • Female
  • Haemophilus Infections / microbiology*
  • Haemophilus influenzae / drug effects
  • Haemophilus influenzae / enzymology*
  • Haemophilus influenzae / isolation & purification*
  • Humans
  • Infant
  • Latin America
  • Male
  • Middle Aged
  • beta-Lactam Resistance*
  • beta-Lactamases / metabolism*
  • beta-Lactams

Substances

  • Anti-Bacterial Agents
  • beta-Lactams
  • beta-Lactamases